nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—NPR1—artery—systemic scleroderma	0.0298	0.126	CbGeAlD
Nitroglycerin—NPR1—endothelium—systemic scleroderma	0.0252	0.106	CbGeAlD
Nitroglycerin—NPR1—blood vessel—systemic scleroderma	0.0233	0.0982	CbGeAlD
Nitroglycerin—GUCY1A2—tendon—systemic scleroderma	0.014	0.0592	CbGeAlD
Nitroglycerin—GUCY1A2—lung—systemic scleroderma	0.0123	0.0519	CbGeAlD
Nitroglycerin—NPR1—connective tissue—systemic scleroderma	0.0119	0.0504	CbGeAlD
Nitroglycerin—NPR1—smooth muscle tissue—systemic scleroderma	0.0109	0.0461	CbGeAlD
Nitroglycerin—ALDH2—connective tissue—systemic scleroderma	0.0108	0.0457	CbGeAlD
Nitroglycerin—ALDH2—smooth muscle tissue—systemic scleroderma	0.0099	0.0418	CbGeAlD
Nitroglycerin—ALDH2—skin of body—systemic scleroderma	0.00977	0.0413	CbGeAlD
Nitroglycerin—GUCY1A3—tendon—systemic scleroderma	0.00883	0.0373	CbGeAlD
Nitroglycerin—GUCY1B3—tendon—systemic scleroderma	0.00876	0.037	CbGeAlD
Nitroglycerin—NPR1—digestive system—systemic scleroderma	0.00861	0.0364	CbGeAlD
Nitroglycerin—NPR1—tendon—systemic scleroderma	0.00819	0.0346	CbGeAlD
Nitroglycerin—ALDH2—digestive system—systemic scleroderma	0.00782	0.033	CbGeAlD
Nitroglycerin—GUCY1A3—lung—systemic scleroderma	0.00774	0.0327	CbGeAlD
Nitroglycerin—GUCY1B3—lung—systemic scleroderma	0.00769	0.0325	CbGeAlD
Nitroglycerin—ALDH2—tendon—systemic scleroderma	0.00744	0.0314	CbGeAlD
Nitroglycerin—NPR1—lung—systemic scleroderma	0.00719	0.0304	CbGeAlD
Nitroglycerin—ALDH2—lung—systemic scleroderma	0.00653	0.0276	CbGeAlD
Nitroglycerin—Infection—Azathioprine—systemic scleroderma	0.00149	0.00195	CcSEcCtD
Nitroglycerin—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00195	CcSEcCtD
Nitroglycerin—Vertigo—Mycophenolic acid—systemic scleroderma	0.00148	0.00194	CcSEcCtD
Nitroglycerin—Syncope—Mycophenolic acid—systemic scleroderma	0.00148	0.00194	CcSEcCtD
Nitroglycerin—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00193	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00146	0.00192	CcSEcCtD
Nitroglycerin—Palpitations—Mycophenolic acid—systemic scleroderma	0.00146	0.00191	CcSEcCtD
Nitroglycerin—Skin disorder—Azathioprine—systemic scleroderma	0.00145	0.0019	CcSEcCtD
Nitroglycerin—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00145	0.0019	CcSEcCtD
Nitroglycerin—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00189	CcSEcCtD
Nitroglycerin—Vomiting—Pentoxifylline—systemic scleroderma	0.00144	0.00188	CcSEcCtD
Nitroglycerin—Rash—Pentoxifylline—systemic scleroderma	0.00143	0.00187	CcSEcCtD
Nitroglycerin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00142	0.00187	CcSEcCtD
Nitroglycerin—Headache—Pentoxifylline—systemic scleroderma	0.00142	0.00186	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00141	0.00185	CcSEcCtD
Nitroglycerin—Feeling abnormal—Captopril—systemic scleroderma	0.00141	0.00185	CcSEcCtD
Nitroglycerin—Infection—Leflunomide—systemic scleroderma	0.0014	0.00184	CcSEcCtD
Nitroglycerin—Vision blurred—Lisinopril—systemic scleroderma	0.0014	0.00184	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Captopril—systemic scleroderma	0.0014	0.00184	CcSEcCtD
Nitroglycerin—Asthenia—Mometasone—systemic scleroderma	0.0014	0.00183	CcSEcCtD
Nitroglycerin—Hypotension—Azathioprine—systemic scleroderma	0.0014	0.00183	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.0014	0.00183	CcSEcCtD
Nitroglycerin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00182	CcSEcCtD
Nitroglycerin—Nervous system disorder—Leflunomide—systemic scleroderma	0.00138	0.00181	CcSEcCtD
Nitroglycerin—Pruritus—Mometasone—systemic scleroderma	0.00138	0.00181	CcSEcCtD
Nitroglycerin—Tachycardia—Leflunomide—systemic scleroderma	0.00138	0.00181	CcSEcCtD
Nitroglycerin—Skin disorder—Leflunomide—systemic scleroderma	0.00137	0.0018	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00137	0.00179	CcSEcCtD
Nitroglycerin—Angioedema—Lisinopril—systemic scleroderma	0.00136	0.00178	CcSEcCtD
Nitroglycerin—Confusional state—Mycophenolic acid—systemic scleroderma	0.00136	0.00178	CcSEcCtD
Nitroglycerin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00178	CcSEcCtD
Nitroglycerin—Body temperature increased—Captopril—systemic scleroderma	0.00135	0.00177	CcSEcCtD
Nitroglycerin—Abdominal pain—Captopril—systemic scleroderma	0.00135	0.00177	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00177	CcSEcCtD
Nitroglycerin—Nausea—Pentoxifylline—systemic scleroderma	0.00134	0.00176	CcSEcCtD
Nitroglycerin—Infection—Mycophenolic acid—systemic scleroderma	0.00134	0.00175	CcSEcCtD
Nitroglycerin—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00175	CcSEcCtD
Nitroglycerin—Vertigo—Lisinopril—systemic scleroderma	0.00134	0.00175	CcSEcCtD
Nitroglycerin—Syncope—Lisinopril—systemic scleroderma	0.00133	0.00175	CcSEcCtD
Nitroglycerin—Renal failure acute—Methotrexate—systemic scleroderma	0.00133	0.00174	CcSEcCtD
Nitroglycerin—Shock—Mycophenolic acid—systemic scleroderma	0.00133	0.00174	CcSEcCtD
Nitroglycerin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00132	0.00173	CcSEcCtD
Nitroglycerin—Hypotension—Leflunomide—systemic scleroderma	0.00132	0.00173	CcSEcCtD
Nitroglycerin—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00131	0.00172	CcSEcCtD
Nitroglycerin—Palpitations—Lisinopril—systemic scleroderma	0.00131	0.00172	CcSEcCtD
Nitroglycerin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00172	CcSEcCtD
Nitroglycerin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00131	0.00171	CcSEcCtD
Nitroglycerin—Loss of consciousness—Lisinopril—systemic scleroderma	0.00131	0.00171	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.0013	0.00171	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.0013	0.0017	CcSEcCtD
Nitroglycerin—Visual disturbance—Methotrexate—systemic scleroderma	0.00129	0.00169	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00129	0.00169	CcSEcCtD
Nitroglycerin—Paraesthesia—Leflunomide—systemic scleroderma	0.00127	0.00166	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00127	0.00166	CcSEcCtD
Nitroglycerin—Dyspnoea—Leflunomide—systemic scleroderma	0.00126	0.00165	CcSEcCtD
Nitroglycerin—Hypotension—Mycophenolic acid—systemic scleroderma	0.00126	0.00165	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00126	0.00165	CcSEcCtD
Nitroglycerin—Vomiting—Mometasone—systemic scleroderma	0.00124	0.00163	CcSEcCtD
Nitroglycerin—Sweating increased—Prednisone—systemic scleroderma	0.00123	0.00162	CcSEcCtD
Nitroglycerin—Feeling abnormal—Azathioprine—systemic scleroderma	0.00123	0.00161	CcSEcCtD
Nitroglycerin—Rash—Mometasone—systemic scleroderma	0.00123	0.00161	CcSEcCtD
Nitroglycerin—Asthenia—Captopril—systemic scleroderma	0.00123	0.00161	CcSEcCtD
Nitroglycerin—Dermatitis—Mometasone—systemic scleroderma	0.00123	0.00161	CcSEcCtD
Nitroglycerin—Confusional state—Lisinopril—systemic scleroderma	0.00122	0.0016	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00122	0.0016	CcSEcCtD
Nitroglycerin—Headache—Mometasone—systemic scleroderma	0.00122	0.0016	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00122	0.0016	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00121	0.00159	CcSEcCtD
Nitroglycerin—Pruritus—Captopril—systemic scleroderma	0.00121	0.00159	CcSEcCtD
Nitroglycerin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00121	0.00158	CcSEcCtD
Nitroglycerin—Infection—Lisinopril—systemic scleroderma	0.00121	0.00158	CcSEcCtD
Nitroglycerin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0012	0.00157	CcSEcCtD
Nitroglycerin—Somnolence—Mycophenolic acid—systemic scleroderma	0.0012	0.00157	CcSEcCtD
Nitroglycerin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00157	CcSEcCtD
Nitroglycerin—Shock—Lisinopril—systemic scleroderma	0.00119	0.00156	CcSEcCtD
Nitroglycerin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00156	CcSEcCtD
Nitroglycerin—Tachycardia—Lisinopril—systemic scleroderma	0.00118	0.00155	CcSEcCtD
Nitroglycerin—Abdominal pain—Azathioprine—systemic scleroderma	0.00118	0.00155	CcSEcCtD
Nitroglycerin—Body temperature increased—Azathioprine—systemic scleroderma	0.00118	0.00155	CcSEcCtD
Nitroglycerin—Skin disorder—Lisinopril—systemic scleroderma	0.00118	0.00154	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00117	0.00154	CcSEcCtD
Nitroglycerin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00153	CcSEcCtD
Nitroglycerin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00153	CcSEcCtD
Nitroglycerin—Feeling abnormal—Leflunomide—systemic scleroderma	0.00116	0.00152	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00116	0.00152	CcSEcCtD
Nitroglycerin—Nausea—Mometasone—systemic scleroderma	0.00116	0.00152	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00115	0.00151	CcSEcCtD
Nitroglycerin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00151	CcSEcCtD
Nitroglycerin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00114	0.0015	CcSEcCtD
Nitroglycerin—Hypotension—Lisinopril—systemic scleroderma	0.00113	0.00149	CcSEcCtD
Nitroglycerin—Dizziness—Captopril—systemic scleroderma	0.00113	0.00148	CcSEcCtD
Nitroglycerin—Urticaria—Leflunomide—systemic scleroderma	0.00112	0.00147	CcSEcCtD
Nitroglycerin—Abdominal pain—Leflunomide—systemic scleroderma	0.00112	0.00146	CcSEcCtD
Nitroglycerin—Body temperature increased—Leflunomide—systemic scleroderma	0.00112	0.00146	CcSEcCtD
Nitroglycerin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00111	0.00145	CcSEcCtD
Nitroglycerin—Hypersensitivity—Azathioprine—systemic scleroderma	0.0011	0.00144	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0011	0.00144	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00144	CcSEcCtD
Nitroglycerin—Paraesthesia—Lisinopril—systemic scleroderma	0.00109	0.00143	CcSEcCtD
Nitroglycerin—Vomiting—Captopril—systemic scleroderma	0.00109	0.00143	CcSEcCtD
Nitroglycerin—Dyspnoea—Lisinopril—systemic scleroderma	0.00108	0.00142	CcSEcCtD
Nitroglycerin—Rash—Captopril—systemic scleroderma	0.00108	0.00142	CcSEcCtD
Nitroglycerin—Dermatitis—Captopril—systemic scleroderma	0.00108	0.00141	CcSEcCtD
Nitroglycerin—Somnolence—Lisinopril—systemic scleroderma	0.00108	0.00141	CcSEcCtD
Nitroglycerin—Headache—Captopril—systemic scleroderma	0.00107	0.00141	CcSEcCtD
Nitroglycerin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00107	0.0014	CcSEcCtD
Nitroglycerin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00106	0.0014	CcSEcCtD
Nitroglycerin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00106	0.0014	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00139	CcSEcCtD
Nitroglycerin—Infection—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00138	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00105	0.00137	CcSEcCtD
Nitroglycerin—Shock—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00137	CcSEcCtD
Nitroglycerin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00137	CcSEcCtD
Nitroglycerin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00104	0.00136	CcSEcCtD
Nitroglycerin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00136	CcSEcCtD
Nitroglycerin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00135	CcSEcCtD
Nitroglycerin—Bradycardia—Prednisone—systemic scleroderma	0.00103	0.00135	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00135	CcSEcCtD
Nitroglycerin—Nausea—Captopril—systemic scleroderma	0.00102	0.00133	CcSEcCtD
Nitroglycerin—Asthenia—Leflunomide—systemic scleroderma	0.00101	0.00133	CcSEcCtD
Nitroglycerin—Feeling abnormal—Lisinopril—systemic scleroderma	0.001	0.00131	CcSEcCtD
Nitroglycerin—Pruritus—Leflunomide—systemic scleroderma	0.000999	0.00131	CcSEcCtD
Nitroglycerin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000993	0.0013	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000992	0.0013	CcSEcCtD
Nitroglycerin—Dizziness—Azathioprine—systemic scleroderma	0.000989	0.0013	CcSEcCtD
Nitroglycerin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000967	0.00127	CcSEcCtD
Nitroglycerin—Urticaria—Lisinopril—systemic scleroderma	0.000964	0.00126	CcSEcCtD
Nitroglycerin—Body temperature increased—Lisinopril—systemic scleroderma	0.000959	0.00126	CcSEcCtD
Nitroglycerin—Abdominal pain—Lisinopril—systemic scleroderma	0.000959	0.00126	CcSEcCtD
Nitroglycerin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000955	0.00125	CcSEcCtD
Nitroglycerin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000953	0.00125	CcSEcCtD
Nitroglycerin—Vomiting—Azathioprine—systemic scleroderma	0.000951	0.00125	CcSEcCtD
Nitroglycerin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000948	0.00124	CcSEcCtD
Nitroglycerin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000945	0.00124	CcSEcCtD
Nitroglycerin—Infestation—Methotrexate—systemic scleroderma	0.000944	0.00124	CcSEcCtD
Nitroglycerin—Infestation NOS—Methotrexate—systemic scleroderma	0.000944	0.00124	CcSEcCtD
Nitroglycerin—Drowsiness—Methotrexate—systemic scleroderma	0.000944	0.00124	CcSEcCtD
Nitroglycerin—Rash—Azathioprine—systemic scleroderma	0.000943	0.00124	CcSEcCtD
Nitroglycerin—Dermatitis—Azathioprine—systemic scleroderma	0.000942	0.00123	CcSEcCtD
Nitroglycerin—Flushing—Prednisone—systemic scleroderma	0.000941	0.00123	CcSEcCtD
Nitroglycerin—Headache—Azathioprine—systemic scleroderma	0.000937	0.00123	CcSEcCtD
Nitroglycerin—Dizziness—Leflunomide—systemic scleroderma	0.000934	0.00122	CcSEcCtD
Nitroglycerin—Stomatitis—Methotrexate—systemic scleroderma	0.00092	0.00121	CcSEcCtD
Nitroglycerin—Angiopathy—Prednisone—systemic scleroderma	0.00092	0.00121	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000918	0.0012	CcSEcCtD
Nitroglycerin—Immune system disorder—Prednisone—systemic scleroderma	0.000916	0.0012	CcSEcCtD
Nitroglycerin—Arrhythmia—Prednisone—systemic scleroderma	0.000906	0.00119	CcSEcCtD
Nitroglycerin—Sweating—Methotrexate—systemic scleroderma	0.000905	0.00119	CcSEcCtD
Nitroglycerin—Vomiting—Leflunomide—systemic scleroderma	0.000898	0.00118	CcSEcCtD
Nitroglycerin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000894	0.00117	CcSEcCtD
Nitroglycerin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000891	0.00117	CcSEcCtD
Nitroglycerin—Rash—Leflunomide—systemic scleroderma	0.00089	0.00117	CcSEcCtD
Nitroglycerin—Dermatitis—Leflunomide—systemic scleroderma	0.00089	0.00117	CcSEcCtD
Nitroglycerin—Mental disorder—Prednisone—systemic scleroderma	0.000889	0.00116	CcSEcCtD
Nitroglycerin—Nausea—Azathioprine—systemic scleroderma	0.000888	0.00116	CcSEcCtD
Nitroglycerin—Headache—Leflunomide—systemic scleroderma	0.000885	0.00116	CcSEcCtD
Nitroglycerin—Erythema—Prednisone—systemic scleroderma	0.000883	0.00116	CcSEcCtD
Nitroglycerin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000876	0.00115	CcSEcCtD
Nitroglycerin—Asthenia—Lisinopril—systemic scleroderma	0.000871	0.00114	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000869	0.00114	CcSEcCtD
Nitroglycerin—Pruritus—Lisinopril—systemic scleroderma	0.000858	0.00112	CcSEcCtD
Nitroglycerin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000857	0.00112	CcSEcCtD
Nitroglycerin—Rash—Mycophenolic acid—systemic scleroderma	0.000849	0.00111	CcSEcCtD
Nitroglycerin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000849	0.00111	CcSEcCtD
Nitroglycerin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000845	0.00111	CcSEcCtD
Nitroglycerin—Headache—Mycophenolic acid—systemic scleroderma	0.000844	0.00111	CcSEcCtD
Nitroglycerin—Pharyngitis—Methotrexate—systemic scleroderma	0.000841	0.0011	CcSEcCtD
Nitroglycerin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00084	0.0011	CcSEcCtD
Nitroglycerin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00084	0.0011	CcSEcCtD
Nitroglycerin—Nausea—Leflunomide—systemic scleroderma	0.000839	0.0011	CcSEcCtD
Nitroglycerin—Vision blurred—Prednisone—systemic scleroderma	0.000832	0.00109	CcSEcCtD
Nitroglycerin—Visual impairment—Methotrexate—systemic scleroderma	0.000817	0.00107	CcSEcCtD
Nitroglycerin—Agitation—Prednisone—systemic scleroderma	0.000811	0.00106	CcSEcCtD
Nitroglycerin—Angioedema—Prednisone—systemic scleroderma	0.000807	0.00106	CcSEcCtD
Nitroglycerin—Dizziness—Lisinopril—systemic scleroderma	0.000802	0.00105	CcSEcCtD
Nitroglycerin—Nausea—Mycophenolic acid—systemic scleroderma	0.0008	0.00105	CcSEcCtD
Nitroglycerin—Vertigo—Prednisone—systemic scleroderma	0.000793	0.00104	CcSEcCtD
Nitroglycerin—Syncope—Prednisone—systemic scleroderma	0.000792	0.00104	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000787	0.00103	CcSEcCtD
Nitroglycerin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000783	0.00103	CcSEcCtD
Nitroglycerin—Loss of consciousness—Prednisone—systemic scleroderma	0.000776	0.00102	CcSEcCtD
Nitroglycerin—Vomiting—Lisinopril—systemic scleroderma	0.000771	0.00101	CcSEcCtD
Nitroglycerin—Angiopathy—Methotrexate—systemic scleroderma	0.000769	0.00101	CcSEcCtD
Nitroglycerin—Immune system disorder—Methotrexate—systemic scleroderma	0.000766	0.001	CcSEcCtD
Nitroglycerin—Rash—Lisinopril—systemic scleroderma	0.000765	0.001	CcSEcCtD
Nitroglycerin—Dermatitis—Lisinopril—systemic scleroderma	0.000764	0.001	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000764	0.001	CcSEcCtD
Nitroglycerin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000763	0.000999	CcSEcCtD
Nitroglycerin—Headache—Lisinopril—systemic scleroderma	0.00076	0.000996	CcSEcCtD
Nitroglycerin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000752	0.000986	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000747	0.000978	CcSEcCtD
Nitroglycerin—Mental disorder—Methotrexate—systemic scleroderma	0.000743	0.000973	CcSEcCtD
Nitroglycerin—Erythema—Methotrexate—systemic scleroderma	0.000738	0.000967	CcSEcCtD
Nitroglycerin—Nausea—Lisinopril—systemic scleroderma	0.000721	0.000944	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000721	0.000944	CcSEcCtD
Nitroglycerin—Infection—Prednisone—systemic scleroderma	0.000716	0.000938	CcSEcCtD
Nitroglycerin—Shock—Prednisone—systemic scleroderma	0.000709	0.000929	CcSEcCtD
Nitroglycerin—Nervous system disorder—Prednisone—systemic scleroderma	0.000707	0.000926	CcSEcCtD
Nitroglycerin—Tachycardia—Prednisone—systemic scleroderma	0.000703	0.000922	CcSEcCtD
Nitroglycerin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000703	0.000921	CcSEcCtD
Nitroglycerin—Skin disorder—Prednisone—systemic scleroderma	0.0007	0.000917	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000697	0.000913	CcSEcCtD
Nitroglycerin—Vision blurred—Methotrexate—systemic scleroderma	0.000695	0.000911	CcSEcCtD
Nitroglycerin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000676	0.000886	CcSEcCtD
Nitroglycerin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00067	0.000878	CcSEcCtD
Nitroglycerin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00067	0.000877	CcSEcCtD
Nitroglycerin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000666	0.000873	CcSEcCtD
Nitroglycerin—Vertigo—Methotrexate—systemic scleroderma	0.000663	0.000869	CcSEcCtD
Nitroglycerin—Paraesthesia—Prednisone—systemic scleroderma	0.000647	0.000848	CcSEcCtD
Nitroglycerin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000631	0.000827	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000624	0.000817	CcSEcCtD
Nitroglycerin—Confusional state—Methotrexate—systemic scleroderma	0.000607	0.000796	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000602	0.000789	CcSEcCtD
Nitroglycerin—Infection—Methotrexate—systemic scleroderma	0.000598	0.000784	CcSEcCtD
Nitroglycerin—Feeling abnormal—Prednisone—systemic scleroderma	0.000594	0.000778	CcSEcCtD
Nitroglycerin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000591	0.000774	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000589	0.000772	CcSEcCtD
Nitroglycerin—Skin disorder—Methotrexate—systemic scleroderma	0.000585	0.000766	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000582	0.000763	CcSEcCtD
Nitroglycerin—Urticaria—Prednisone—systemic scleroderma	0.000572	0.00075	CcSEcCtD
Nitroglycerin—Body temperature increased—Prednisone—systemic scleroderma	0.00057	0.000746	CcSEcCtD
Nitroglycerin—Abdominal pain—Prednisone—systemic scleroderma	0.00057	0.000746	CcSEcCtD
Nitroglycerin—Hypotension—Methotrexate—systemic scleroderma	0.000563	0.000737	CcSEcCtD
Nitroglycerin—Paraesthesia—Methotrexate—systemic scleroderma	0.000541	0.000709	CcSEcCtD
Nitroglycerin—Dyspnoea—Methotrexate—systemic scleroderma	0.000537	0.000704	CcSEcCtD
Nitroglycerin—Somnolence—Methotrexate—systemic scleroderma	0.000535	0.000702	CcSEcCtD
Nitroglycerin—Hypersensitivity—Prednisone—systemic scleroderma	0.000531	0.000696	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00052	0.000681	CcSEcCtD
Nitroglycerin—Asthenia—Prednisone—systemic scleroderma	0.000517	0.000677	CcSEcCtD
Nitroglycerin—Pruritus—Prednisone—systemic scleroderma	0.00051	0.000668	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000496	0.00065	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000492	0.000645	CcSEcCtD
Nitroglycerin—Urticaria—Methotrexate—systemic scleroderma	0.000478	0.000627	CcSEcCtD
Nitroglycerin—Dizziness—Prednisone—systemic scleroderma	0.000477	0.000624	CcSEcCtD
Nitroglycerin—Body temperature increased—Methotrexate—systemic scleroderma	0.000476	0.000624	CcSEcCtD
Nitroglycerin—Abdominal pain—Methotrexate—systemic scleroderma	0.000476	0.000624	CcSEcCtD
Nitroglycerin—Vomiting—Prednisone—systemic scleroderma	0.000458	0.0006	CcSEcCtD
Nitroglycerin—Rash—Prednisone—systemic scleroderma	0.000454	0.000595	CcSEcCtD
Nitroglycerin—Dermatitis—Prednisone—systemic scleroderma	0.000454	0.000595	CcSEcCtD
Nitroglycerin—Headache—Prednisone—systemic scleroderma	0.000451	0.000592	CcSEcCtD
Nitroglycerin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000444	0.000581	CcSEcCtD
Nitroglycerin—Asthenia—Methotrexate—systemic scleroderma	0.000432	0.000566	CcSEcCtD
Nitroglycerin—Nausea—Prednisone—systemic scleroderma	0.000428	0.000561	CcSEcCtD
Nitroglycerin—Pruritus—Methotrexate—systemic scleroderma	0.000426	0.000558	CcSEcCtD
Nitroglycerin—Dizziness—Methotrexate—systemic scleroderma	0.000398	0.000522	CcSEcCtD
Nitroglycerin—Vomiting—Methotrexate—systemic scleroderma	0.000383	0.000502	CcSEcCtD
Nitroglycerin—Rash—Methotrexate—systemic scleroderma	0.00038	0.000498	CcSEcCtD
Nitroglycerin—Dermatitis—Methotrexate—systemic scleroderma	0.000379	0.000497	CcSEcCtD
Nitroglycerin—Headache—Methotrexate—systemic scleroderma	0.000377	0.000494	CcSEcCtD
Nitroglycerin—Nausea—Methotrexate—systemic scleroderma	0.000358	0.000469	CcSEcCtD
